| Primary |
| Hepatitis C |
66.7% |
| Anaemia |
33.3% |
|
| Splenic Rupture |
50.0% |
| Sudden Death |
50.0% |
|
| Secondary |
| Drug Use For Unknown Indication |
27.4% |
| Hepatitis C |
15.1% |
| Product Used For Unknown Indication |
14.7% |
| Anaemia |
6.9% |
| Renal Failure Chronic |
4.8% |
| Epilepsy |
4.3% |
| Hypertension |
3.0% |
| Herpes Zoster |
2.6% |
| Prophylaxis |
2.5% |
| Coronary Artery Disease |
2.4% |
| Nephrogenic Anaemia |
2.4% |
| Renal Failure |
2.4% |
| Myelodysplastic Syndrome |
2.3% |
| Pain |
1.5% |
| Depression |
1.4% |
| Hepatitis |
1.3% |
| Breast Cancer Metastatic |
1.2% |
| Hepatitis B |
1.2% |
| Immunosuppression |
1.2% |
| Multiple Myeloma |
1.2% |
|
| Aplasia Pure Red Cell |
29.0% |
| Urosepsis |
16.3% |
| Drug Effect Decreased |
6.5% |
| Herpes Zoster |
6.2% |
| Myelodysplastic Syndrome |
6.2% |
| Venous Insufficiency |
5.4% |
| Panmyelopathy |
3.7% |
| Thrombocytopenia |
3.7% |
| Haemoglobin Decreased |
3.1% |
| Post Procedural Complication |
2.8% |
| General Physical Health Deterioration |
2.5% |
| Pancytopenia |
2.0% |
| Vomiting |
2.0% |
| Death |
1.7% |
| Hyperkalaemia |
1.7% |
| No Therapeutic Response |
1.7% |
| Anaemia |
1.4% |
| Normochromic Normocytic Anaemia |
1.4% |
| Pyrexia |
1.4% |
| Wegener's Granulomatosis |
1.4% |
|
| Concomitant |
| Product Used For Unknown Indication |
39.1% |
| Hepatitis C |
13.6% |
| Drug Use For Unknown Indication |
12.5% |
| Anaemia |
6.1% |
| Hypertension |
5.2% |
| Prophylaxis |
4.4% |
| Hyperparathyroidism Secondary |
2.6% |
| Multiple Myeloma |
2.3% |
| Breast Cancer |
1.8% |
| Renal Transplant |
1.7% |
| Hiv Infection |
1.6% |
| Non-small Cell Lung Cancer |
1.6% |
| Pain |
1.5% |
| Diffuse Large B-cell Lymphoma |
1.1% |
| Renal Failure Chronic |
1.0% |
| Prophylaxis Against Transplant Rejection |
0.9% |
| Chest Pain |
0.8% |
| Hyperparathyroidism |
0.7% |
| Pruritus |
0.7% |
| Hypothyroidism |
0.7% |
|
| Thrombocytopenia |
14.3% |
| Anaemia |
9.8% |
| Pyrexia |
8.2% |
| Nephrogenic Systemic Fibrosis |
6.1% |
| Vomiting |
5.5% |
| Lung Disorder |
4.9% |
| Rash |
4.6% |
| Cardiac Arrest |
4.0% |
| Death |
4.0% |
| Febrile Neutropenia |
4.0% |
| Renal Failure Acute |
4.0% |
| Swelling |
4.0% |
| Weight Decreased |
3.7% |
| Aplasia Pure Red Cell |
3.4% |
| General Physical Health Deterioration |
3.4% |
| Neutropenia |
3.4% |
| Tachycardia |
3.4% |
| Toxic Epidermal Necrolysis |
3.4% |
| Urinary Tract Infection |
3.4% |
| Pulmonary Embolism |
3.0% |
|
| Interacting |
| Hepatitis C |
66.7% |
| Drug Use For Unknown Indication |
33.3% |
|
|
